Researchers have developed a new method that could make enzyme replacement therapy more efficient for Pompe disease treatment.
List view / Grid view
An airway-on-a-chip has been used to show that amodiaquine inhibits SARS-CoV-2 infection, making it a potential COVID-19 therapeutic.
Researchers studying the PLpro binding site of three coronaviruses, including SARS-CoV-2, say the BL2 loop could be targeted by antiviral drugs.
A new vaccine against the Staphylococcus aureus infection has proven effective in experiments with mice, with an 80 percent survival rate.
A study has revealed the role of a protein which enables human cytomegalovirus to spread, the number one cause of congenital birth defects in the world.
The discovery and development of novel drug candidates is a highly complex, time-consuming and expensive process. Pharmaceutical scientists and clinicians should, therefore, reevaluate and modify the existing standard platforms and increase their uptake of robust advanced technologies such as flow cytometry to overcome the bottlenecks in these processes...
4 May 2016 | By Victoria White, Digital Content Producer
Researchers have identified a metabolite of ketamine, hydroxynorketamine, that quickly reverses depression in mice, but without ketamine's side effects...
21 July 2015 | By
Researchers have now shown that a “messenger molecule” produced by P. aeruginosa encourage bacteria to colonise catheters, forming a biofilm...